MediWound Ltd. (MDWD), a developer of next-generation enzymatic therapeutics for tissue repair, has a regulatory catalyst to watch in the coming months.
The company has sought FDA approval to expand the use of its flagship product in paediatric setting and a decision is expected in the second half of this year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.